Target & Activity
| Target | Activity | Value |
|---|---|---|
| Reverse transcriptase |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| 143B | IC50 | 12.25 μM | Cytotoxicity against human 143B cells after 72 hrs by MTT assay | [PMID: 25440502] |
| 143B | IC50 | 148.42 μM | Cytotoxicity against human thymidine kinase-deficient 143B cells after 72 hrs by MTT assay | [PMID: 25440502] |
| 5637 | IC50 | 128.82 μM | Antiproliferative activity in human 5637 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay | [PMID: 30108758] |
| 5637 | IC50 | 7 μM | Cytotoxicity against human 5637 cells assessed as growth inhibition after 48 hrs by MTT assay | [PMID: 25811955] |
| A549 | IC50 | 0.011 μM | Inhibition of Influenza A virus (A/Viet Nam/1203/2004(H5N1)) hemagglutininin-mediated viral entry into human A549 cells assessed as luciferase activity after 48 hrs postinfection by luminometry | [PMID: 19537689] |
| A549 | IC50 | 0.012 μM | Inhibition of Influenza A virus (A/Bar-headed Goose/Qinghai/59/05(H5N1)) hemagglutininin-mediated viral entry into human A549 cells assessed as luciferase activity after 48 hrs postinfection by luminometry | [PMID: 19537689] |
| A549 | IC50 | 11.86 μM | Cytotoxicity in human A549 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay | [PMID: 31400940] |
| A549 | IC50 | 16.19 μM | Cytotoxicity against human A549 cells after 48 hrs by SRB method | [PMID: 25933593] |
| AA5 | IC50 | < 0.0003 μM | Antiviral activity against of Human immunodeficiency virus 1 3B infected in AA5 cells infected with 1.56 uL of virus stock assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay | [PMID: 20086149] |
| AA5 | IC50 | > 0.1 μM | Cytotoxicity against human AA5 cells by MTS assay | [PMID: 20086149] |
| AA5 | IC50 | 0.0003 μM | Antiviral activity against of Human immunodeficiency virus 1 3B infected in AA5 cells infected with 0.78 uL of virus stock assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay | [PMID: 20086149] |
| AA5 | IC50 | 0.0004 μM | Antiviral activity against of Human immunodeficiency virus 1 3B infected in AA5 cells infected with 3.13 uL of virus stock assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay | [PMID: 20086149] |
| AA5 | IC50 | 0.006 μM | Antiviral activity against Human immunodeficiency virus 1 3B infected in AA5 cells infected with 0.78 uL of virus stock assessed as expression of p24 antigen after 6 days postinfection by ELISA | [PMID: 20086149] |
| AA5 | IC50 | 0.008 μM | Antiviral activity against Human immunodeficiency virus 1 3B infected in AA5 cells infected with 3.13 uL of virus stock assessed as expression of p24 antigen after 6 days postinfection by ELISA | [PMID: 20086149] |
| AA5 | IC50 | 0.009 μM | Antiviral activity against Human immunodeficiency virus 1 3B infected in AA5 cells infected with 1.56 uL of virus stock assessed as expression of p24 antigen after 6 days postinfection by ELISA | [PMID: 20086149] |
| B(EBV+) | EC50 | 0.001 μM | Effective concentration required for antiviral activity against B(EBV+) cell line of AA5 cells of Human by XTT assay | [PMID: 7932526] |
| Bel-7402 | EC50 | 4.62 μM | Cytotoxicity against human Bel7402 cells after 48 hrs by MTT assay | [PMID: 18313175] |
| Bone marrow cell | CC50 | 0.5 μM | Cytotoxicity against human bone marrow cells after 24 hrs by BFU-E assay | [PMID: 20439609] |
| Bone marrow cell | CC50 | 0.89 μM | Cytotoxicity against human bone marrow cells after 24 hrs by GM-CFU assay | [PMID: 20439609] |
19 records · Scroll to view more